Table 2.
IAS-related drugs and the number of cases (N).
| Related drugs | N |
|---|---|
| Methimazole | 170 (21.38%) |
| Alpha lipoic acid | 51 (6.42%) |
| Clopidogrel | 8 (1.01%) |
| Esomeprazole | 1 (0.13%) |
| Captopril | 8 (1.01%) |
| Insulin and its analogues | 20 (2.52%) |
| Sulfhydryl-containing health products | 2 (0.25%) |
| Insulin aspartate 30 | 27 (3.40%) |
| Insulin glargine | 2 (0.25%) |
| Glucosamine sulfate-containing drugs | 1 (0.13%) |
| Insulin lispro | 3 (0.38%) |
| 131I therapy | 2 (0.25%) |
| Mercaptan | 2 (0.25%) |
| Tiopronin | 54 (6.80%) |
| Zinc protamine recombinant human insulin | 11 (1.38%) |
| Acetylcysteine | 1 (0.13%) |
| Penicillamine | 2 (0.25%) |
| Carbimazole | 3 (0.38%) |
| Propylthiouracil | 3 (0.38%) |
| Penicillin G | 1 (0.13%) |
| Ganshulin 50R | 2 (0.25%) |
| Coenzyme Q10 | 1 (0.13%) |
| Omeprazole | 1 (0.13%) |
| Human serum albumin | 1 (0.13%) |
| Antituberculosis treatment | 2 (0.25%) |
| Loxoprofen sodium | 2 (0.25%) |
| Insulin glulisine | 1 (0.13%) |
| Pantoprazole | 1 (0.13%) |
| Methionine-containing supplements | 1 (0.13%) |
| Imipenem | 1 (0.13%) |
| Azathioprine | 1 (0.13%) |
| Glimepiride | 1 (0.13%) |
| Glutathione | 8 (1.01%) |
| Gold thioglucoce | 1 (0.13%) |
| Acegratone | 1 (0.13%) |
| Interferon-alfa | 1 (0.13%) |
| Gliclazide | 1 (0.13%) |
| Unknown or no | 399 (50.19%) |
| Total | 795 |